Maximus, Inc. (NYSE:MMS) Shares Sold by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP decreased its position in Maximus, Inc. (NYSE:MMS - Free Report) by 58.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,084 shares of the health services provider's stock after selling 14,026 shares during the period. ExodusPoint Capital Management LP's holdings in Maximus were worth $753,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. UMB Bank n.a. increased its position in shares of Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after acquiring an additional 158 shares during the last quarter. Eastern Bank acquired a new stake in Maximus in the 4th quarter valued at approximately $29,000. V Square Quantitative Management LLC raised its position in Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after purchasing an additional 180 shares during the period. R Squared Ltd acquired a new position in Maximus during the fourth quarter worth $54,000. Finally, IFP Advisors Inc grew its stake in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after buying an additional 302 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Insider Buying and Selling

In other news, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on MMS. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price on the stock in a research note on Thursday, January 2nd. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.

Maximus Stock Up 0.1 %

NYSE:MMS traded up $0.04 during midday trading on Thursday, reaching $67.42. The company had a trading volume of 49,810 shares, compared to its average volume of 547,246. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The firm has a market capitalization of $3.82 billion, a price-to-earnings ratio of 14.48 and a beta of 0.68. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The stock's fifty day simple moving average is $67.66 and its 200-day simple moving average is $75.76.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, sell-side analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.78%. Maximus's payout ratio is 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.